Pluri Inc. (PLUR) Insider Trading Activity

NASDAQ$1.24-0.03 (-2.36%)
Market Cap
$13.7M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
718 of 849
Rank in Industry
411 of 491

PLUR Insider Trading Activity

PLUR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
1
100
Sells
$0
0
0

Related Transactions

Manieu Alexandre Weinstein
1
$0
0
$0
$0

About Pluri Inc.

Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in advanced clinical development, with ongoing Phase III trials for muscle recovery after hip fracture surgery, Phase II studies for acute respiratory distress …

Insider Activity of Pluri Inc.

Over the last 12 months, insiders at Pluri Inc. have bought $0 and sold $0 worth of Pluri Inc. stock.

On average, over the past 5 years, insiders at Pluri Inc. have bought $1.55M and sold $1,940 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 833,334 shares for transaction amount of $0 was made by Manieu Alexandre Weinstein () on 2026‑10‑23.

List of Insider Buy and Sell Transactions, Pluri Inc.

2026-10-23PurchaseManieu Alexandre Weinstein
833,334
–
$0
$0
+21.21%
2025-04-28PurchaseManieu Alexandre Weinstein
976,139
11.5449%
$4.61
$4.5M
-16.98%
2022-12-20SaleAberman Zamidirector
2,000
0.0062%
$0.97
$1,940
-19.19%
2022-02-10PurchaseAberman Zamidirector
80,616
0.4663%
$1.80
$145,109
-36.99%
2021-05-28SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
115,007
1.3749%
$3.72
$427,826
-32.34%
2021-05-27SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
95,885
1.137%
$3.69
$353,816
-31.97%
2021-05-26SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
144,678
1.7117%
$3.68
$532,635
-32.25%
2021-05-25SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
261,238
3.2238%
$3.84
$1M
-31.32%
2021-05-24SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
79,300
0.976%
$3.83
$303,719
-33.95%
2021-05-21SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
69,838
0.8932%
$3.98
$277,955
-35.17%
2021-05-03SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
23,721
0.3263%
$4.28
$101,526
-37.50%
2021-04-30SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
166,004
2.486%
$4.66
$773,579
-37.03%
2020-11-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.6234%
$9.70
$194,000
-60.93%
2020-10-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
50,000
1.5281%
$9.51
$475,500
-54.05%
2020-10-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.5913%
$9.20
$184,000
-53.92%
2020-09-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
139,006
4.619%
$10.34
$1.44M
-54.65%
2020-09-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
60,123
1.8858%
$9.76
$586,800
-52.72%
2020-09-28PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
13,189
0.4022%
$9.49
$125,164
-49.42%
2020-09-24PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
34,800
1.0087%
$9.02
$313,896
-45.34%
2020-09-23PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
10,734
0.3117%
$9.04
$96,983
-46.14%
Total: 116
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Manieu Alexandre Weinstein
2083334
19.3089%
$2.65M20
<0.0001%
YANAY YAKYCo-CEO & President
4253045
39.4184%
$5.4M117
+5.92%
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
3121918
28.9348%
$3.96M288
<0.0001%
MERETSKI SHAI10 percent owner
2400000
22.2438%
$3.05M10
Aberman Zamidirector
1491973
13.828%
$1.89M138
+1.11%
BRAUN ISAACdirector
636208
5.8965%
$807,984.1610
<0.0001%
SHORRER DORONdirector
464744
4.3074%
$590,224.8831
+30.05%
BEN-YORAM ISRAELdirector
387235
3.589%
$491,788.45712
+6.81%
Kwiat Moriadirector
373571
3.4624%
$474,435.1712
<0.0001%
Gur-Lavie BoazChief Financial Officer
59228
0.5489%
$75,219.5610
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Pluri Inc.
(PLUR)
$18,815,063
62
-6.45%
$13.7M
$1,993,425
46
-21.91%
$13.95M
$95,567,744
39
-17.01%
$10.94M
$30,257,839
29
-15.72%
$12M
$76,600
22
-38.58%
$10.49M

PLUR Institutional Investors: Active Positions

Increased Positions2+8.33%98+0.19%
Decreased Positions7-29.17%26,140-50.29%
New Positions<1New20New
Sold Out Positions5Sold Out12,139Sold Out
Total Postitions19-20.83%25,937-50.1%

PLUR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Renaissance Technologies Llc$101.000.38%33,925+6,505+23.72%2025-09-30
Values First Advisors, Inc.$36.000.13%11,907-217-1.79%2025-09-30
Morgan Stanley$9.000.04%3,177+94+3.05%2025-09-30
Eversource Wealth Advisors, Llc$6.000.02%2,00000%2025-09-30
Wells Fargo & Company/Mn$1.00<0.01%18500%2025-09-30
Zurcher Kantonalbank (Zurich Cantonalbank)$0<0.01%13600%2025-09-30
Jpmorgan Chase & Co$0<0.01%12500%2025-09-30
Royal Bank Of Canada$0<0.01%12500%2025-09-30
Td Waterhouse Canada Inc.$0<0.01%9300%2025-09-30
Quent Capital, Llc$0<0.01%57+57New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.